Rappler's latest stories on remdesivir
Australia approves remdesivir as virus treatment
It is the first drug approved by Australian authorities to treat the virus and promised to reduce hospitalization time for coronavirus patients
EU authorizes use of remdesivir to treat coronavirus
'Today's authorization of a first medicine to treat COVID-19 is an important step forward in the fight against this virus,' says EU Health Commissioner Stella Kyriakides
U.S. buys up COVID-19 drug, as some countries say they are well-stocked
Washington announces it had purchased 92% of all remdesivir production by the Gilead laboratory until the end of September – about 500,000 treatments out of nearly 550,000
Patients in need of remdesivir can get special FDA permits
Currently, the Philippines only administers remdesivir to hospitalized patients with severe cases of coronavirus
EU body recommends use of remdesivir to treat coronavirus
'Remdesivir is the first medicine against COVID-19 to be recommended for authorization in the EU,' the European Medicines Agency says
Singapore approves anti-viral drug for coronavirus patients
Remdesivir is granted conditional approval in Singapore for treatment of some adult virus patients, such as those who require intensive breathing support
South Korea approves remdesivir for virus patients
A South Korean government review of remdesivir research says it has proven 'clinically meaningful' in cutting patients' recovery times
US govt agency study finds anti-viral drug effective against coronavirus
However, the result is just below the statistical reliability threshold, meaning it could be down to chance rather than the capability of the drug
Japan approves remdesivir for coronavirus treatment
This makes Japan the second country to approve the drug after US regulators authorized it for emergency use against severe cases of COVID-19
Coronavirus drugs: Who's doing what, and when they might come
Treatment could come sooner, with antiviral remdesivir showing early promise and already being used on an ad hoc basis before regulatory approval
